Porphyromonas gingivalis is a Gram-negative anaerobic bacterium that is closely related to periodontal diseases and has strong virulence. Studies have shown that in addition to damaging oral health, it also has a serious impact on general health. This article reviews the research progress of the relationship between Porphyromonas gingivalis and human diseases, which is helpful to explore new treatment strategies for related diseases.

Yangtao Hu. Research progress on the correlation between porphyromonas gingivalis and human diseases. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 2: 1-7. https://doi.org/10.25236/IJFM.2023.050201.

[1] NIH HMP Working Group, Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J. A., Bonazzi, V., McEwen, J. E., Wetterstrand, K. A., Deal, C., Baker, C. C., Di Francesco, V., Howcroft, T. K., Karp, R. W., Lunsford, R. D., Wellington, C. R., Belachew, T., Wright, M., Giblin, C., … Guyer, M. (2009). The NIH Human Microbiome Project. Genome research, 19(12), 2317–2323.

[2] Gao, L., Xu, T., Huang, G., Jiang, S., Gu, Y., & Chen, F. (2018). Oral microbiomes: more and more importance in oral cavity and whole body. Protein & cell, 9(5), 488–500.

[3] Issrani, R., Reddy, J., Dabah, T. H. E., Prabhu, N., Alruwaili, M. K., Munisekhar, M. S., Alshammari, S. M., & Alghumaiz, S. F. (2022). Exploring the Mechanisms and Association between Oral Microflora and Systemic Diseases. Diagnostics (Basel, Switzerland), 12(11), 2800.

[4] Jia, X., Liu, J., He, Y., & Huang, X. (2022). Porphyromonas gingivalis secretion leads to dysplasia of normal esophageal epithelial cells via the Sonic hedgehog pathway. Frontiers in cellular and infection microbiology, 12, 982636.

[5] Li, Y., Cui, J., Liu, Y., Chen, K., Huang, L., & Liu, Y. (2021). Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research. Frontiers in cardiovascular medicine, 8, 730203.

[6] Lavigne S. E. (2022). Evolving evidence for relationships between periodontitis and systemic diseases: Position paper from the Canadian Dental Hygienists Association. Canadian journal of dental hygiene : CJDH = Journal canadien de l'hygiene dentaire : JCHD, 56(3), 155–171.

[7] Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L., Jr (1998). Microbial complexes in subgingival plaque. Journal of clinical periodontology, 25(2), 134–144.

[8] de Andrade, K. Q., Almeida-da-Silva, C. L. C., & Coutinho-Silva, R. (2019). Immunological Pathways Triggered by Porphyromonas gingivalis and Fusobacterium nucleatum: Therapeutic Possibilities? Mediators of inflammation, 2019, 7241312.

[9] Zhang, J. S., Chu, C. H., & Yu, O. Y. (2022). Oral Microbiome and Dental Caries Development. Dentistry journal, 10(10), 184.

[10] Jiang, Q., Liu, J., Chen, L., Gan, N., & Yang, D. (2019). The Oral Microbiome in the Elderly With Dental Caries and Health. Frontiers in cellular and infection microbiology, 8, 442.

[11] Pignatelli, P., Romei, F. M., Bondi, D., Giuliani, M., Piattelli, A., & Curia, M. C. (2022). Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis. International journal of molecular sciences, 23(15), 8323.

[12] Kuboniwa, M., Hasegawa, Y., Mao, S., Shizukuishi, S., Amano, A., Lamont, R. J., & Yilmaz, O. (2008). P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes and infection, 10(2), 122–128.

[13] Pushalkar, S., Mane, S. P., Ji, X., Li, Y., Evans, C., Crasta, O. R., Morse, D., Meagher, R., Singh, A., & Saxena, D. (2011). Microbial diversity in saliva of oral squamous cell carcinoma. FEMS immunology and medical microbiology, 61(3), 269–277. 

[14] Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I., & Cha, S. (2011). Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. International journal of oral science, 3(4), 209–215.

[15] Yu, M., Li, T., Liu, T., He, L. F., Tian, T. T., & Chen, J. (2022). Shanghai kou qiang yi xue = Shanghai journal of stomatology, 31(1), 100–103.

[16] Liu, Y., Yuan, X., Chen, K., Zhou, F., Yang, H., Yang, H., Qi, Y., Kong, J., Sun, W., & Gao, S. (2021). Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer. Translational oncology, 14(1), 100972.

[17] Gao, S., Li, S., Ma, Z., Liang, S., Shan, T., Zhang, M., Zhu, X., Zhang, P., Liu, G., Zhou, F., Yuan, X., Jia, R., Potempa, J., Scott, D. A., Lamont, R. J., Wang, H., & Feng, X. (2016). Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infectious agents and cancer, 11, 3.

[18] Chen, M. F., Lu, M. S., Hsieh, C. C., & Chen, W. C. (2021). Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cellular oncology (Dordrecht), 44(2), 373–384. 

[19] Guo, Y., Liu, Y., Yang, H., Dai, N., Zhou, F., Yang, H., Sun, W., Kong, J., Yuan, X., & Gao, S. (2021). Associations of Porphyromonas gingivalis Infection and Low Beclin1 Expression With Clinicopathological Parameters and Survival of Esophageal Squamous Cell Carcinoma Patients. Pathology oncology research: POR, 27, 1609976.

[20] Hujoel, P. P., Drangsholt, M., Spiekerman, C., & Weiss, N. S. (2003). An exploration of the periodontitis-cancer association. Annals of epidemiology, 13(5), 312–316.

[21] Gnanasekaran, J., Binder Gallimidi, A., Saba, E., Pandi, K., Eli Berchoer, L., Hermano, E., Angabo, S., Makkawi, H. A., Khashan, A., Daoud, A., Elkin, M., & Nussbaum, G. (2020). Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells. Cancers, 12(8), 2331.

[22] Michaud, D. S., Izard, J., Wilhelm-Benartzi, C. S., You, D. H., Grote, V. A., Tjønneland, A., Dahm, C. C., Overvad, K., Jenab, M., Fedirko, V., Boutron-Ruault, M. C., Clavel-Chapelon, F., Racine, A., Kaaks, R., Boeing, H., Foerster, J., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Sacerdote, C., … Riboli, E. (2013). Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut, 62(12), 1764–1770.

[23] Corrêa, J. D., Fernandes, G. R., Calderaro, D. C., Mendonça, S. M. S., Silva, J. M., Albiero, M. L., Cunha, F. Q., Xiao, E., Ferreira, G. A., Teixeira, A. L., Mukherjee, C., Leys, E. J., Silva, T. A., & Graves, D. T. (2019). Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Scientific reports, 9(1), 8379.

[24] Cheng, Z., Do, T., Mankia, K., Meade, J., Hunt, L., Clerehugh, V., Speirs, A., Tugnait, A., Emery, P., & Devine, D. (2021). Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the rheumatic diseases, 80(2), 162–168.

[25] Corrêa, J. D., Calderaro, D. C., Ferreira, G. A., Mendonça, S. M., Fernandes, G. R., Xiao, E., Teixeira, A. L., Leys, E. J., Graves, D. T., & Silva, T. A. (2017). Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome, 5(1), 34.

[26] Neculae, E., Gosav, E. M., Valasciuc, E., Dima, N., Floria, M., & Tanase, D. M. (2023). The Oral Microbiota in Valvular Heart Disease: Current Knowledge and Future Directions. Life (Basel, Switzerland), 13(1), 182.

[27] Patel, U. K., Malik, P., Kodumuri, N., Patel, P., Pitti, V., Tyagi, G., Chauhan, B., Lunagariya, A., Kothari, R., & Sen, S. (2020). Chronic Periodontitis is Associated with Cerebral Atherosclerosis -A Nationwide Study. Cureus, 12(11), e11373.

[28] Silva, M. V. F., Loures, C. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. D. G. (2019). Alzheimer's disease: risk factors and potentially protective measures. Journal of biomedical science, 26(1), 33.

[29] Chen, C. K., Wu, Y. T., & Chang, Y. C. (2017). Association between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study. Alzheimer's research & therapy, 9(1), 56.

[30] Pritchard, A. B., Fabian, Z., Lawrence, C. L., Morton, G., Crean, S., & Alder, J. E. (2022). An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins in a Human in vitro Model. Journal of Alzheimer's disease: JAD, 86(1), 343–364. 

[31] Dioguardi, M., Crincoli, V., Laino, L., Alovisi, M., Sovereto, D., Mastrangelo, F., Russo, L. L., & Muzio, L. L. (2020). The Role of Periodontitis and Periodontal Bacteria in the Onset and Progression of Alzheimer's Disease: A Systematic Review. Journal of clinical medicine, 9(2), 495.

[32] Costa, M. J. F., de Araújo, I. D. T., da Rocha Alves, L., da Silva, R. L., Dos Santos Calderon, P., Borges, B. C. D., de Aquino Martins, A. R. L., de Vasconcelos Gurgel, B. C., & Lins, R. D. A. U. (2021). Relationship of Porphyromonas gingivalis and Alzheimer's disease: a systematic review of pre-clinical studies. Clinical oral investigations, 25(3), 797–806.

[33] Radochova, V., Kacerovska Musilova, I., Stepan, M., Vescicik, P., Slezak, R., Jacobsson, B., & Kacerovsky, M. (2018). Periodontal disease and intra-amniotic complications in women with preterm prelabor rupture of membranes. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 31(21), 2852–2861.

[34] Radochova, V., Stepan, M., Kacerovska Musilova, I., Slezak, R., Vescicik, P., Menon, R., Jacobsson, B., & Kacerovsky, M. (2019). Association between periodontal disease and preterm prelabour rupture of membranes. Journal of clinical periodontology, 46(2), 189–196. 

[35] Mahendra, J., Mahendra, L., Sharma, V., Alamoudi, A., Bahammam, H. A., Mugri, M. H., Bahammam, S. A., Bahammam, M. A., Zidane, B., Abirami Nayaki, R. P., Muralidharan, J., Dave, P. H., Balaji, T. M., Bhandi, S., & Patil, S. (2022). Red-Complex Bacterial Levels in Pregnant Women with Preeclampsia and Chronic Periodontitis. International dental journal, S0020-6539(22)00229-5. Advance online publication.

[36] Moncunill-Mira, J., Brunet-Llobet, L., Cuadras, D., Lorente-Colomé, N., Pascal, R., Rovira, C., Nadal, A., & Miranda-Rius, J. (2021). Do the clinical criteria used to diagnose periodontitis affect the association with prematurity?. Odontology, 109(2), 455–463.

[37] Ye, C. C., & Wu, Y. F. (2022). Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 57(6), 635–641.

[38] Amarasekara, R., Jayasekara, R. W., Senanayake, H., & Dissanayake, V. H. (2015). Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia. The journal of obstetrics and gynaecology research, 41(5), 662–669.

[39] Victor, V. M., Rocha, M., Bañuls, C., Alvarez, A., de Pablo, C., Sanchez-Serrano, M., Gomez, M., & Hernandez-Mijares, A. (2011). Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. The Journal of clinical endocrinology and metabolism, 96(10), 3115–3122.

[40] Akcalı, A., Bostanci, N., Özçaka, Ö., Öztürk-Ceyhan, B., Gümüş, P., Buduneli, N., & Belibasakis, G. N. (2014). Association between polycystic ovary syndrome, oral microbiota and systemic antibody responses. PloS one, 9(9), e108074.

[41] Márquez-Arrico, C. F., Silvestre-Rangil, J., Gutiérrez-Castillo, L., Martinez-Herrera, M., Silvestre, F. J., & Rocha, M. (2020). Association between Periodontal Diseases and Polycystic Ovary Syndrome: A Systematic Review. Journal of clinical medicine, 9(5), 1586.

[42] Machado, V., Escalda, C., Proença, L., Mendes, J. J., & Botelho, J. (2020). Is There a Bidirectional Association between Polycystic Ovarian Syndrome and Periodontitis? A Systematic Review and Meta-analysis. Journal of clinical medicine, 9(6), 1961.